Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.39 CAD | -1.29% | -9.98% | +51.44% |
Mar. 15 | Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024 | |
Mar. 14 | Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023. | CI |
Sales 2024 * | 28.87M 21.07M | Sales 2025 * | 29.33M 21.4M | Capitalization | 202M 148M |
---|---|---|---|---|---|
Net income 2024 * | 12M 8.76M | Net income 2025 * | 13M 9.49M | EV / Sales 2024 * | 7.01 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.9 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
19.4
x | Employees | 5 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.49% |
Latest transcript on Cipher Pharmaceuticals Inc.
1 day | -1.29% | ||
1 week | -9.98% | ||
Current month | -5.73% | ||
1 month | -8.41% | ||
3 months | +46.42% | ||
6 months | +87.70% | ||
Current year | +51.44% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 19-03-25 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 22-08-14 |
James Bowen
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 16-08-07 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 23-06-20 |
Craig Mull
CEO | Chief Executive Officer | - | 19-03-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 8.39 | -1.29% | 10,586 |
24-04-19 | 8.5 | -3.35% | 23,709 |
24-04-18 | 8.795 | -0.28% | 30,931 |
24-04-17 | 8.82 | -1.01% | 6,227 |
24-04-16 | 8.91 | -4.40% | 19,017 |
Delayed Quote Toronto S.E., April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.44% | 147M | |
+25.46% | 659B | |
+25.38% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.13% | 215B | |
+2.93% | 210B | |
-7.65% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- CPH Stock